Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SNCG contributors: mct/npt/pgu - updated : 06-01-2010
HGNC name synuclein, gamma (breast cancer-specific protein 1)
HGNC id 11141
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Endocrineadrenal gland   highly
Nervousbrainmidbrainsubstantia nigra highly
 nervecranial nerve  highly
Visualeyeretina  highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Epithelialsensoryvisualganglion cell layerhighly
Nervousperipherous  highly
cells
SystemCellPubmedSpeciesStageRna symbol
Nervousglia
Nervousneuron
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period perinatal
Text during pre and postnatal development in the cell bodies and axons of primary sensory neurons,sympathetic neurons and motoneurons of peripheral and central nervous system
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • six imperfect repeats of 11 aminoacids with the consensus core KTKEGV
  • HOMOLOGY
    Homologene
    FAMILY
  • neuronal protein family synuclein
  • CATEGORY transport carrier
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic
    intracellular,cytoplasm,cytoskeleton,microtubule,centrosome
    intracellular,cytoplasm,cytoskeleton,microtubule,mitotic spindle
    basic FUNCTION
  • may be involved in exocytosis of synaptic vesicles
  • may be a centrosome-associated protein
  • playing a role in neurofilament network integrity
  • regulates many pathways in growth and progression of breast cancer
  • role in promoting a more robust G protein activation of PLCB2
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • able to bind directly to several transcription factors
  • competes for GNAQ association, but not for activators that bind to the N-terminus
  • binding of SNCG reduces the catalytic activity of PLCB2 by mechanism that involves inhibition of product release without affecting membrane interactions
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in ovarian carcinoma, and in breast carcinomas but not in normal epithelium
    tumoral     --over  
    in hepatocellular carcinoma, with distant metastasis and demethylation of SNCG CpG island is an early sign of genetic abnormality in liver cirrhosis preceding hepatocarcinogenesis
    tumoral     --over  
    in pancreatic cancer correlated with major invasive parameters, including perineural invasion and lymph node metastasis
    Susceptibility to neurologic disease (but not Parkinson disease)
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    may serve as a promising molecular target of early diagnosis and anticancer therapy
    cancerreproductivebreast
    potential target for breast cancer treatment
    ANIMAL & CELL MODELS